Reports and Findings
Research
Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitorsThe early years of life have a profound effect on a child's developmental pathway.
Research
Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapyIn adults, the unpredictability of voriconazole pharmacokinetics, particularly in those patients receiving chemotherapy, is well recognised. A paucity of...
Research
Fusionfinder: A software tool to identify expressed gene fusion candidates from RNA-seq dataThe hallmarks of many haematological malignancies and solid tumours are chromosomal translocations, which may lead to gene fusions.
Research
Wound healing genes and susceptibility to cutaneous leishmaniasis in BrazilLeishmania braziliensis causes cutaneous (CL) and mucosal (ML) leishmaniasis. In the mouse, Fli1 was identified as a gene influencing enhanced wound healing...
Research
Prevalence of and risk factors for human rhinovirus infection in healthy aboriginal and non-aboriginal western australian childrenHuman rhinovirus (HRV) species C (HRV-C) have been associated with frequent and severe acute lower respiratory infections and asthma in hospitalized children.
Research
Adjusting for under-identification of Aboriginal and/or Torres Strait Islander births in time series produced from birth recordsStatistical time series derived from administrative data sets form key indicators in measuring progress.
Research
Multiple sclerosis: A disease of affluence?Multiple sclerosis is rare in tropical areas, but quite common in developed countries.
Research
Hypoallergenic der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergyMore than 50% of allergic patients have house dust mite (HDM) allergy.
Research
Increase in caesarean deliveries after the australian private health insurance incentive policy reformsThe Australian Private Health Insurance Incentive (PHII) policy reforms implemented in 1997-2000 increased PHI membership in Australia by 50%.
Research
Clarithromycin therapy for patients with Cystic Fibrosis: A randomized controlled trialThe clinically significant actions of oral azithromycin in modifying progressive cystic fibrosis (CF) lung disease have been well documented.